Updated Jul 16, 2026
Grant-Huerta Yanina has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $54K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-20 | ATRA | Atara Biotherapeutics, Inc. | S — Open-market sale | 2.4K | $9.13 | $22K |
| 2026-03-11 | ATRA | Atara Biotherapeutics, Inc. | A — Grant or award | 20.3K | $0.00 | |
| 2026-03-04 | ATRA | Atara Biotherapeutics, Inc. | S — Open-market sale | 100 | $5.08 | $508 |
| 2026-03-04 | ATRA | Atara Biotherapeutics, Inc. | S — Open-market sale | 377 | $5.08 | $2K |
| 2026-03-04 | ATRA | Atara Biotherapeutics, Inc. | S — Open-market sale | 1.6K | $5.08 | $8K |
| 2026-03-04 | ATRA | Atara Biotherapeutics, Inc. | S — Open-market sale | 24 | $5.08 | $122 |
| 2025-08-18 | ATRA | Atara Biotherapeutics, Inc. | S — Open-market sale | 1.7K | $11.61 | $19K |
| 2025-08-18 | ATRA | Atara Biotherapeutics, Inc. | S — Open-market sale | 86 | $11.61 | $999 |
| 2025-08-18 | ATRA | Atara Biotherapeutics, Inc. | S — Open-market sale | 55 | $11.61 | $638 |
Grant-Huerta Yanina is a corporate insider — currently tracked as Insider of Atara Biotherapeutics, Inc. (ATRA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($54K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Grant-Huerta Yanina profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.